These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22028905)

  • 1. Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells.
    Kurzawa L; Pellerano M; Coppolani JB; Morris MC
    PLoS One; 2011; 6(10):e26555. PubMed ID: 22028905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent protein biosensor for probing CDK/cyclin activity in vitro and in living cells.
    Van TN; Pellerano M; Lykaso S; Morris MC
    Chembiochem; 2014 Oct; 15(15):2298-305. PubMed ID: 25209885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
    Prével C; Kurzawa L; Van TN; Morris MC
    Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent Peptide Biosensors for Probing CDK Kinase Activity in Cell Extracts.
    Pellerano M; Morris MC
    Methods Mol Biol; 2021; 2329():39-50. PubMed ID: 34085214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
    Morris MC
    Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies.
    Prével C; Pellerano M; González-Vera JA; Henri P; Meunier L; Vollaire J; Josserand V; Morris MC
    Biosens Bioelectron; 2016 Nov; 85():371-380. PubMed ID: 27203461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the functional diversity of the CDK-cyclin family.
    Wood DJ; Endicott JA
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in cyclin-dependent kinase biochemical and structural studies.
    Echalier A; Endicott JA; Noble ME
    Biochim Biophys Acta; 2010 Mar; 1804(3):511-9. PubMed ID: 19822225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
    Montagnoli A; Fiore F; Eytan E; Carrano AC; Draetta GF; Hershko A; Pagano M
    Genes Dev; 1999 May; 13(9):1181-9. PubMed ID: 10323868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing the metazoan proliferation-quiescence decision in vivo.
    Adikes RC; Kohrman AQ; Martinez MAQ; Palmisano NJ; Smith JJ; Medwig-Kinney TN; Min M; Sallee MD; Ahmed OB; Kim N; Liu S; Morabito RD; Weeks N; Zhao Q; Zhang W; Feldman JL; Barkoulas M; Pani AM; Spencer SL; Martin BL; Matus DQ
    Elife; 2020 Dec; 9():. PubMed ID: 33350383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-binding motifs are essential for the function of p21CIP1.
    Chen J; Saha P; Kornbluth S; Dynlacht BD; Dutta A
    Mol Cell Biol; 1996 Sep; 16(9):4673-82. PubMed ID: 8756624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts.
    Soamalala J; Diot S; Pellerano M; Blanquart C; Galibert M; Jullian M; Puget K; Morris MC
    Chembiochem; 2021 Mar; 22(6):1065-1071. PubMed ID: 33112024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity.
    Premnath PN; Craig SN; Liu S; Anderson EL; Grigoroudis AI; Kontopidis G; Perkins TL; Wyatt MD; Pittman DL; McInnes C
    J Med Chem; 2015 Jan; 58(1):433-42. PubMed ID: 25454794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less-well known functions of cyclin/CDK complexes.
    Palmer N; Kaldis P
    Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.